Down-regulating α-synuclein for treating synucleopathies.

Mathieu Bourdenx, Benjamin Dehay, Erwan Bezard
Mov Disord.. 2014-09-12; 29(12): 1463-1465
DOI: 10.1002/mds.26028


Lire sur PubMed

---

1. Mov Disord. 2014 Oct;29(12):1463-5. doi: 10.1002/mds.26028. Epub 2014 Sep 12.

Down-regulating α-synuclein for treating synucleopathies.

Bourdenx M(1), Dehay B, Bezard E.

Author information:
(1)Institute of Neurodegenerative Diseases, University of Bordeaux, Centre
National de la Recherche Scientifique Unité Mixte de Recherche, Bordeaux, France.

Comment on
Mov Disord. 2014 Oct;29(12):1476-85.

DOI: 10.1002/mds.26028
PMID: 25214445 [Indexed for MEDLINE]

Auteurs Bordeaux Neurocampus